Ryota Tanaka

1.2k total citations
90 papers, 850 citations indexed

About

Ryota Tanaka is a scholar working on Oncology, Pharmacology and Epidemiology. According to data from OpenAlex, Ryota Tanaka has authored 90 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Pharmacology and 16 papers in Epidemiology. Recurrent topics in Ryota Tanaka's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Ryota Tanaka is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Ryota Tanaka collaborates with scholars based in Japan, Australia and United States. Ryota Tanaka's co-authors include Hiroki Itoh, Masaki Otagiri, Hiroshi Watanabe, Yosuke Suzuki, Victor Tuan Giam Chuang, Yu Ishima, Toru Maruyama, Yuhki Sato, Toru Maruyama and Masafumi Fukagawa and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ryota Tanaka

81 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryota Tanaka Japan	16	295	127	110	97	88	90	850
Estelle Marrer Switzerland	11	236 0.8×	83 0.7×	94 0.9×	39 0.4×	90 1.0×	13	885
Bianca Maria Goffredo Italy	21	457 1.5×	127 1.0×	99 0.9×	133 1.4×	95 1.1×	78	1.3k
Jaroslav Chládek Czechia	22	188 0.6×	155 1.2×	120 1.1×	26 0.3×	150 1.7×	66	1.2k
Sarah Shugarts United States	9	130 0.4×	259 2.0×	63 0.6×	76 0.8×	60 0.7×	13	691
Qingqing Xiao China	18	392 1.3×	84 0.7×	40 0.4×	41 0.4×	136 1.5×	50	995
Kentaro Sugiyama Japan	15	273 0.9×	113 0.9×	124 1.1×	32 0.3×	52 0.6×	70	715
Maryam Moossavi Iran	15	449 1.5×	137 1.1×	44 0.4×	50 0.5×	68 0.8×	44	1.1k
Donald F. LeGatt Canada	18	300 1.0×	84 0.7×	209 1.9×	109 1.1×	51 0.6×	60	1.2k
Peter R. Gwilt United States	17	229 0.8×	207 1.6×	93 0.8×	62 0.6×	72 0.8×	44	963

Countries citing papers authored by Ryota Tanaka

Since Specialization

Citations

This map shows the geographic impact of Ryota Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Tanaka more than expected).

Fields of papers citing papers by Ryota Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Tanaka. The network helps show where Ryota Tanaka may publish in the future.

Co-authorship network of co-authors of Ryota Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Tanaka. A scholar is included among the top collaborators of Ryota Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Tanaka. Ryota Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Ryota, Hiroshi Abe, Tomoko Saito, et al.. (2025). Sensitive quantification of free lenvatinib using ultra-high performance liquid chromatography coupled to tandem mass spectrometry and the clinical significance of measuring free lenvatinib concentration. Clinica Chimica Acta. 569. 120188–120188.

Tanaka, Ryota, Yosuke Suzuki, Takashi Inagaki, et al.. (2025). Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin‐I as an Endogenous Biomarker. Clinical Pharmacology & Therapeutics. 118(1). 128–137.

Suzuki, Yosuke, Ryota Tanaka, Hiroyuki Ono, et al.. (2024). Rapid and simple quantification of belimumab in human plasma using ultra-high performance liquid chromatography with tandem mass spectrometry. Clinical Biochemistry. 124. 110706–110706. 2 indexed citations

Ono, Hiroyuki, Ryota Tanaka, Yosuke Suzuki, et al.. (2024). Relationship of plasma 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease. Clinical and Translational Science. 17(2). e13731–e13731. 2 indexed citations

Tanaka, Ryota, et al.. (2024). Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: A retrospective propensity score analysis. British Journal of Clinical Pharmacology. 91(5). 1409–1418.

Suzuki, Yosuke, Ryota Tanaka, Hiroyuki Ono, et al.. (2024). Evaluation of intra‐ and inter‐individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus. Pharmacology Research & Perspectives. 12(4). e1255–e1255. 1 indexed citations

Tanaka, Ryota, Yosuke Suzuki, Koji Goto, et al.. (2022). UHPLC–MS/MS method for simultaneous quantification of doripenem, meropenem, ciprofloxacin, levofloxacin, pazufloxacin, linezolid, and tedizolid in filtrate during continuous renal replacement therapy. Journal of Clinical Laboratory Analysis. 37(1). e24815–e24815. 4 indexed citations

Tanaka, Ryota, et al.. (2021). Exacerbation of cancer pain after administering immune checkpoint inhibitor in a patient taking opioids: A case report. Journal of Clinical Pharmacy and Therapeutics. 47(4). 552–555. 4 indexed citations

Tanaka, Ryota, et al.. (2021). High-throughput simultaneous quantification of five azole anti-fungal agents and one active metabolite in human plasma using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry. Clinical Biochemistry. 99. 87–96. 9 indexed citations

10.

Matsumoto, Asami, Yosuke Suzuki, Kazuhiro Tanaka, et al.. (2021). Sensitive quantification of free pazopanib using ultra-high performance liquid chromatography coupled to tandem mass spectrometry and assessment of clinical application. Journal of Pharmaceutical and Biomedical Analysis. 206. 114348–114348. 7 indexed citations

11.

Tanaka, Ryota, et al.. (2020). A retrospective test for a possible relationship between linezolid‐induced thrombocytopenia and hyponatraemia. Journal of Clinical Pharmacy and Therapeutics. 46(2). 343–351. 7 indexed citations

12.

Fukunaga, Masaki, Daisuke Kadowaki, Mika Mori, et al.. (2020). In vivo evaluation of drug dialyzability in a rat model of hemodialysis. PLoS ONE. 15(6). e0233925–e0233925. 4 indexed citations

13.

Suzuki, Yosuke, Kazuhiro Tanaka, Masanori Kawano, et al.. (2020). Development of a High-Throughput Quantification Method for Pazopanib Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Clinical Application in Patients With Soft Tissue Tumors. Therapeutic Drug Monitoring. 43(3). 416–421. 3 indexed citations

14.

Suzuki, Yosuke, Takashi Fujioka, Fuminori Sato, et al.. (2018). Factors involved in phenoconversion of CYP3A using 4β-hydroxycholesterol in stable kidney transplant recipients. Pharmacological Reports. 71(2). 276–281. 12 indexed citations

15.

Watanabe, Hiroshi, Hitoshi Maeda, Keisuke Hamasaki, et al.. (2018). Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery. Journal of Controlled Release. 277. 23–34. 26 indexed citations

16.

Goto, Koji, Yuhki Sato, Seigo Hidaka, et al.. (2016). Pharmacokinetics of ceftriaxone in patients undergoing continuous renal replacement therapy. Journal of Basic and Clinical Physiology and Pharmacology. 27(6). 625–631. 7 indexed citations

17.

Kinoshita, Ryo, Yu Ishima, Mayumi Ikeda, et al.. (2015). S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes. Journal of Controlled Release. 217. 1–9. 46 indexed citations

18.

Tanaka, Ryota, Yu Ishima, Hitoshi Maeda, et al.. (2014). Albumin Fusion Prolongs the Antioxidant and Anti-Inflammatory Activities of Thioredoxin in Mice with Acetaminophen-Induced Hepatitis. Molecular Pharmaceutics. 11(4). 1228–1238. 21 indexed citations

19.

Watanabe, Hiroshi, Ryota Tanaka, Victor Tuan Giam Chuang, et al.. (2013). Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(3). 1152–1162. 53 indexed citations

20.

Tanaka, Ryota, et al.. (1998). P-30 A Survey of Sperm Analyses on Reproductive Toxicity Studies in Rats.. Congenital Anomalies. 38(3). 337. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact